| Cara Cameron, CNM | |
|
3024 New Bern Ave, Raleigh, NC 27610-1247 | |
| (919) 350-7844 | |
| Not Available |
| Full Name | Cara Cameron |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 20 Years |
| Location | 3024 New Bern Ave, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477579035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 346 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wakemed Specialists Group Llc | 2466788377 | 690 |
News Archive
One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition. The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition.
Researchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.
› Verified 1 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition. The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition.
Researchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.
› Verified 1 days ago
| Entity Name | Wakemed Specialists Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588227839 PECOS PAC ID: 2466788377 Enrollment ID: O20190731000815 |
News Archive
One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition. The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition.
Researchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cara Cameron, CNM 2920 Highwoods Blvd, Raleigh, NC 27604-0010 Ph: (877) 498-4490 | Cara Cameron, CNM 3024 New Bern Ave, Raleigh, NC 27610-1247 Ph: (919) 350-7844 |
News Archive
One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition. The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition.
Researchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.
› Verified 1 days ago
Chelsey Hilscher, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 10 Sunnybrook Road, Clinic G, Wchs, Raleigh, NC 27610 Phone: 919-250-4701 | |
Mrs. Tianna Kathryn Powell Greene, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4414 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-351-8253 | |
Jessica Lynn Albrecht, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4414 Lake Boone Trl Ste 402, Raleigh, NC 27607 Phone: 919-567-6133 | |
Lisa Stevens, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 10 Sunnybrook Rd, Raleigh, NC 27610 Phone: 919-212-7000 | |
Mrs. Julie Ann Stembridge, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3024 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-7331 | |
Kathryn Anne Wood Calvillo, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4414 Lake Boone Trl Ste 300, Raleigh, NC 27607 Phone: 919-781-5510 | |
Cassandra Lagod, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1500 Garner Rd, Raleigh, NC 27610 Phone: 919-556-1008 |